Home/Investors/Pfizer

Pfizer

Biotech Investor · 4 portfolio companies

Portfolio

4

Combined Value

$5.6B

Focus Areas

8

Top Stage

Phase 1/2

Investment Focus

Hematology Oncology Genetic Disorders Metabolic Diseases Liver Diseases Infectious Diseases Travel Medicine Autoimmune Diseases

Portfolio Companies

Company	Stage	Valuation	Focus
Beam Therapeutics	Phase 1/2	$2.5B	Hematology, Oncology
Zymeworks	Phase 3	$1.7B	Oncology
Valneva SE	Commercial	$896.6M	Infectious Diseases, Travel Medicine
Allogene Therapeutics	Phase 2	$465.2M	Oncology, Autoimmune Diseases

Frequent Co-Investors

Public shareholders1 shared BlackRock1 shared Atlas Venture1 shared Arch Venture Partners1 shared Third Rock Ventures1 shared Fidelity Management & Research Company1 shared Wellington Management1 shared Apellis Pharmaceuticals1 shared